Cargando…

Age-related terminal duct lobular unit involution in benign tissues from Chinese breast cancer patients with luminal and triple-negative tumors

BACKGROUND: Terminal duct lobular unit (TDLU) involution is a physiological process of breast tissue aging characterized by a reduction in the epithelial component. In studies of women with benign breast disease, researchers have found that age-matched women with lower levels of TDLU involution are...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Changyuan, Sung, Hyuna, Zheng, Shan, Guida, Jennifer, Li, Erni, Li, Jing, Hu, Nan, Deng, Joseph, Figueroa, Jonine D., Sherman, Mark E., Gierach, Gretchen L., Lu, Ning, Yang, Xiaohong R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445352/
https://www.ncbi.nlm.nih.gov/pubmed/28545469
http://dx.doi.org/10.1186/s13058-017-0850-5
_version_ 1783238870055256064
author Guo, Changyuan
Sung, Hyuna
Zheng, Shan
Guida, Jennifer
Li, Erni
Li, Jing
Hu, Nan
Deng, Joseph
Figueroa, Jonine D.
Sherman, Mark E.
Gierach, Gretchen L.
Lu, Ning
Yang, Xiaohong R.
author_facet Guo, Changyuan
Sung, Hyuna
Zheng, Shan
Guida, Jennifer
Li, Erni
Li, Jing
Hu, Nan
Deng, Joseph
Figueroa, Jonine D.
Sherman, Mark E.
Gierach, Gretchen L.
Lu, Ning
Yang, Xiaohong R.
author_sort Guo, Changyuan
collection PubMed
description BACKGROUND: Terminal duct lobular unit (TDLU) involution is a physiological process of breast tissue aging characterized by a reduction in the epithelial component. In studies of women with benign breast disease, researchers have found that age-matched women with lower levels of TDLU involution are at increased risk of developing breast cancer. We previously showed that breast cancer cases with core basal phenotype (CBP; estrogen receptor negative [ER(−)], progesterone receptor-negative [PR(−)], human epidermal growth factor receptor 2-negative [HER2(−)], cytokeratins (CK 5 or CK5/6)-positive [CK5/6(+)] and/or epidermal growth factor receptor-positive [EGFR(+)]) tumors had significantly reduced TDLU involution compared with cases with luminal A (ER(+) and/or PR(+), HER2(−), CK5/6(−), EGFR(−)) tumors from a population-based case-control study in Poland. We evaluated the association of TDLU involution with tumor subtypes in an independent population of women in China, where the breast cancer incidence rate, prevalence of known risk factors, and mammographic breast density are thought to be markedly different from those of Polish women. METHODS: We performed morphometric assessment of TDLUs by using three reproducible semiquantitative measures that inversely correlate with TDLU involution (TDLU count/100 mm(2), TDLU span in micrometer, and acini count/TDLU) by examining benign tissue blocks from 254 age-matched luminal A and 250 triple-negative (TN; ER(−), PR(−), HER2(−), including 125 CBP) breast cancer cases treated in a tertiary hospital in Beijing, China. RESULTS: Overall, we found that TN and particularly CBP cases tended to have greater TDLU measures (less involution) than luminal A cases in logistic regression models accounting for age, body mass index, parity, and tumor grade. The strongest association was observed for tertiles of acini count among younger women (aged <50 years) (CBP vs. luminal A; OR(trend) 2.11, 95% CI 1.22–3.67, P = 0.008). CONCLUSIONS: These data extend previous findings that TN/CBP breast cancers are associated with reduced TDLU involution in surrounding breast parenchyma compared with luminal A cases among Chinese women, providing further support for differences in the pathogenesis of these tumor subtypes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13058-017-0850-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5445352
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54453522017-05-30 Age-related terminal duct lobular unit involution in benign tissues from Chinese breast cancer patients with luminal and triple-negative tumors Guo, Changyuan Sung, Hyuna Zheng, Shan Guida, Jennifer Li, Erni Li, Jing Hu, Nan Deng, Joseph Figueroa, Jonine D. Sherman, Mark E. Gierach, Gretchen L. Lu, Ning Yang, Xiaohong R. Breast Cancer Res Research Article BACKGROUND: Terminal duct lobular unit (TDLU) involution is a physiological process of breast tissue aging characterized by a reduction in the epithelial component. In studies of women with benign breast disease, researchers have found that age-matched women with lower levels of TDLU involution are at increased risk of developing breast cancer. We previously showed that breast cancer cases with core basal phenotype (CBP; estrogen receptor negative [ER(−)], progesterone receptor-negative [PR(−)], human epidermal growth factor receptor 2-negative [HER2(−)], cytokeratins (CK 5 or CK5/6)-positive [CK5/6(+)] and/or epidermal growth factor receptor-positive [EGFR(+)]) tumors had significantly reduced TDLU involution compared with cases with luminal A (ER(+) and/or PR(+), HER2(−), CK5/6(−), EGFR(−)) tumors from a population-based case-control study in Poland. We evaluated the association of TDLU involution with tumor subtypes in an independent population of women in China, where the breast cancer incidence rate, prevalence of known risk factors, and mammographic breast density are thought to be markedly different from those of Polish women. METHODS: We performed morphometric assessment of TDLUs by using three reproducible semiquantitative measures that inversely correlate with TDLU involution (TDLU count/100 mm(2), TDLU span in micrometer, and acini count/TDLU) by examining benign tissue blocks from 254 age-matched luminal A and 250 triple-negative (TN; ER(−), PR(−), HER2(−), including 125 CBP) breast cancer cases treated in a tertiary hospital in Beijing, China. RESULTS: Overall, we found that TN and particularly CBP cases tended to have greater TDLU measures (less involution) than luminal A cases in logistic regression models accounting for age, body mass index, parity, and tumor grade. The strongest association was observed for tertiles of acini count among younger women (aged <50 years) (CBP vs. luminal A; OR(trend) 2.11, 95% CI 1.22–3.67, P = 0.008). CONCLUSIONS: These data extend previous findings that TN/CBP breast cancers are associated with reduced TDLU involution in surrounding breast parenchyma compared with luminal A cases among Chinese women, providing further support for differences in the pathogenesis of these tumor subtypes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13058-017-0850-5) contains supplementary material, which is available to authorized users. BioMed Central 2017-05-25 2017 /pmc/articles/PMC5445352/ /pubmed/28545469 http://dx.doi.org/10.1186/s13058-017-0850-5 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Guo, Changyuan
Sung, Hyuna
Zheng, Shan
Guida, Jennifer
Li, Erni
Li, Jing
Hu, Nan
Deng, Joseph
Figueroa, Jonine D.
Sherman, Mark E.
Gierach, Gretchen L.
Lu, Ning
Yang, Xiaohong R.
Age-related terminal duct lobular unit involution in benign tissues from Chinese breast cancer patients with luminal and triple-negative tumors
title Age-related terminal duct lobular unit involution in benign tissues from Chinese breast cancer patients with luminal and triple-negative tumors
title_full Age-related terminal duct lobular unit involution in benign tissues from Chinese breast cancer patients with luminal and triple-negative tumors
title_fullStr Age-related terminal duct lobular unit involution in benign tissues from Chinese breast cancer patients with luminal and triple-negative tumors
title_full_unstemmed Age-related terminal duct lobular unit involution in benign tissues from Chinese breast cancer patients with luminal and triple-negative tumors
title_short Age-related terminal duct lobular unit involution in benign tissues from Chinese breast cancer patients with luminal and triple-negative tumors
title_sort age-related terminal duct lobular unit involution in benign tissues from chinese breast cancer patients with luminal and triple-negative tumors
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445352/
https://www.ncbi.nlm.nih.gov/pubmed/28545469
http://dx.doi.org/10.1186/s13058-017-0850-5
work_keys_str_mv AT guochangyuan agerelatedterminalductlobularunitinvolutioninbenigntissuesfromchinesebreastcancerpatientswithluminalandtriplenegativetumors
AT sunghyuna agerelatedterminalductlobularunitinvolutioninbenigntissuesfromchinesebreastcancerpatientswithluminalandtriplenegativetumors
AT zhengshan agerelatedterminalductlobularunitinvolutioninbenigntissuesfromchinesebreastcancerpatientswithluminalandtriplenegativetumors
AT guidajennifer agerelatedterminalductlobularunitinvolutioninbenigntissuesfromchinesebreastcancerpatientswithluminalandtriplenegativetumors
AT lierni agerelatedterminalductlobularunitinvolutioninbenigntissuesfromchinesebreastcancerpatientswithluminalandtriplenegativetumors
AT lijing agerelatedterminalductlobularunitinvolutioninbenigntissuesfromchinesebreastcancerpatientswithluminalandtriplenegativetumors
AT hunan agerelatedterminalductlobularunitinvolutioninbenigntissuesfromchinesebreastcancerpatientswithluminalandtriplenegativetumors
AT dengjoseph agerelatedterminalductlobularunitinvolutioninbenigntissuesfromchinesebreastcancerpatientswithluminalandtriplenegativetumors
AT figueroajonined agerelatedterminalductlobularunitinvolutioninbenigntissuesfromchinesebreastcancerpatientswithluminalandtriplenegativetumors
AT shermanmarke agerelatedterminalductlobularunitinvolutioninbenigntissuesfromchinesebreastcancerpatientswithluminalandtriplenegativetumors
AT gierachgretchenl agerelatedterminalductlobularunitinvolutioninbenigntissuesfromchinesebreastcancerpatientswithluminalandtriplenegativetumors
AT luning agerelatedterminalductlobularunitinvolutioninbenigntissuesfromchinesebreastcancerpatientswithluminalandtriplenegativetumors
AT yangxiaohongr agerelatedterminalductlobularunitinvolutioninbenigntissuesfromchinesebreastcancerpatientswithluminalandtriplenegativetumors